The pathogenesis of hepatocellular carcinoma (HCC) is not fully understood, which has
affected the early diagnosis and treatment of HCC and the survival time of patients.
MicroRNAs (miRNAs) are a class of evolutionarily conserved small, non-coding RNAs,
which regulate the expression of various genes post-transcriptionally. Emerging
evidence indicates that the key enzymes involved in the miRNA biosynthesis pathway
and some tumor-specific miRNAs are widely deregulated or upregulated in HCC and
closely associated with the occurrence and development of various cancers, including
HCC. Early studies have shown that miRNAs have critical roles in HCC progression by
targeting many critical protein-coding genes, thereby contributing to the promotion
of cell proliferation; the avoidance of apoptosis, inducing via angiogenesis; and the
activation of invasion and metastasis pathways. Experimental data indicate that
discovery of increasing numbers of aberrantly expressed miRNAs has opened up a new
field for investigating the molecular mechanism of HCC progression. In this review,
we describe the current knowledge about the roles and validated targets of miRNAs in
the above pathways that are known to be hallmarks of HCC, and we also describe the
influence of genetic variations in miRNA biosynthesis and genes.